Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients
Author:
Affiliation:
1. AIDS Healthcare Foundation, Los Angeles, California.
2. Gilead Sciences, Foster City, California.
Publisher
Mary Ann Liebert Inc
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Link
http://www.liebertpub.com/doi/pdf/10.1089/apc.2005.19.135
Reference7 articles.
1. Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected AdultsA Randomized Equivalence Trial
2. Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals
3. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors
4. Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine
5. The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2017-12-11
2. More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1;eLife;2016-02-14
3. A systematic review of a single-class maintenance strategy with nucleoside reverse transcriptase inhibitors in HIV/AIDS;Antiviral Therapy;2014
4. Recent advances in antiretroviral treatment and prevention in HIV-infected patients;Current Opinion in HIV and AIDS;2011-12
5. Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells;Pharmaceutics;2011-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3